Skip to content
MarketNewsAPI
Product Live news Screener Coverage Pricing
Docs Overview REST API WebSocket API MCP server
Resources Use cases Blog Changelog Status Compare Contact
Log in Get API key Dashboard
AMZN$271.31+5.28(+1.98%)Global Delivery Drones Market by Payload, Range, MTOW, Platform, Application, and Region - Forecast to 2031 | Healthcare and Hybrid Drones Fuel 21.6% CAGR to $7.65 Billion9:23:39 AM ETAMD$451.23-37.55(-7.68%)Heterogeneous Computing Market Size and Share - Industry Trends and Growth Forecasts (2026-2031) | Generative AI and Cloud Adoption Fuel 21.87% CAGR9:20:42 AM ETAMD$451.23-37.55(-7.68%)Global Accelerated Computing Market Size, Share, Industry Trends, and Growth Forecasts, 2026-2031 | AI Training and Edge Inference Fuel 20.19% CAGR and Custom Silicon Opportunities9:19:40 AM ETFISI$40.44+1.09(+2.77%)Virtual Desktop Infrastructure (VDI) Endpoint Market Size, Share, Trends, and Forecast 2026-2031 | Hybrid Work and Zero Trust Drive 14.48% CAGR Toward USD 9.89 Billion9:18:45 AM ETMSFT$555.76-0.04(-0.01%)Carbon-Aware Computing Platform Market Size, Share, Trends, and Growth Forecasts, 2026-2031 | AI Demand and ESG Mandates Propel Market to USD 2.95 Billion9:17:39 AM ETSOLV$89.56+0.21(+0.24%)UAE Hospital Supplies Market Size and Share Analysis, Industry Trends, and Growth Forecasts, 2026-2031 | AI Procurement and Infection-Control Demand Fuel 8.10% CAGR9:11:38 AM ETACN$268.20+3.93(+1.49%)Application Outsourcing - Market Size, Share, Industry Trends, and Growth Forecasts, 2026-2031 | Cloud, AI, and Security Demand Drive Market to USD 215.46 Billion9:10:49 AM ETCSCO$100.38-3.28(-3.16%)Desktop Virtualization Market Size, Share, Trends, and Growth Forecasts, 2026-2031 | Cloud DaaS and Hybrid Work Propel Market to USD 20.54 Billion as Asia-Pacific Leads Growth9:09:39 AM ETIBM$255.55+1.23(+0.48%)Industrial Edge Computing Market Size, Share, Trends, and Growth Forecasts, 2026-2031 | Edge AI, IIoT, and Private-5G Drive 13.24% CAGR to USD 114.87 Billion9:08:39 AM ETQUBT$6.22-0.21(-3.27%)Next-generation Computing Market Size, Share, Trends, and Growth Forecasts 2026-2031 | AI, Quantum, and Edge Investment Drive 19.02% CAGR to USD 650.48 Billion9:07:40 AM ETDIS$119.95+1.00(+0.84%)I've Been Writing About Disney Stock for 30 Years. Here's Why My Conviction Has Never Been Higher.9:07:00 AM ETKO$96.82+0.94(+0.98%)Digital Transformation (DX) - Market Size, Share, Trends, and Growth Forecasts, 2026-2031 | AI and Cloud Adoption Drive Growth to USD 5.33 Trillion9:05:41 AM ETMSFT$555.76-0.04(-0.01%)Not One Analyst Rates Microsoft a Sell. Is the Consensus View Right?9:05:39 AM ETLLY$1,433.97+15.83(+1.12%)Prediction: The Weight-Loss Drug Boom Could Be Just the Beginning for Lilly9:03:54 AM ETBNTX$90.62-0.02(-0.02%)Messenger Ribonucleic Acid (mRNA) Manufacturing Service Market Report 2026 | Capitalize on 16.2% CAGR in IVT and LNP with Thermo Fisher, Merck, Lonza and GenScript ProBio9:03:39 AM ETMSFT$555.76-0.04(-0.01%)Green IT Software Market Size, Share, Trends, and Growth Forecasts, 2026-2031 | ESG Mandates and AI Optimization Propel Market to USD 49.35 Billion9:02:40 AM ETAMZN$271.31+5.28(+1.98%)CEO Andy Jassy Just Told Investors That AWS Can Grow Revenue 40% in 2027 and 2028 and Eventually Become a Trillion-Dollar Business. Is It Enough to Get Wall Street on Board?9:02:00 AM ETTEM$73.01-2.61(-3.45%)Personal Genome Services Market Report 2026: Global Forecast to 2030 | Market to Reach $13.69 Billion by 2030 as Personalized Medicine Adoption Accelerates9:01:40 AM ETVZ$46.68+0.51(+1.10%)Verizon announces cap increases and expiration and results of its tender offers for five series of notes9:00:57 AM ETJPM$358.02+5.80(+1.65%)Chase Travel Unveils 27 Trips to Take in 2027 and Previews Expanded Luxury Vacation Homes Offering9:00:16 AM ETAMGN$481.21+2.73(+0.57%)REPATHA® LOWERS RISK OF HEART ATTACKS BY 20% COMPARED WITH EZETIMIBE IN A LARGE REAL-WORLD STUDY9:00:00 AM ETTM$216.00+16.54(+8.29%)Forterra and May Mobility Advance to Phase III of DIU’s ROADS Challenge, Bringing Autonomous Rides to Soldiers on Military Bases9:00:00 AM ETTXN$301.50-10.10(-3.24%)XGIMI and Kickstarter Present NYC Innovation Showcase Featuring Record-Breaking AURA 3 Series Projector9:00:00 AM ETTM$216.00+16.54(+8.29%)2027 Toyota RAV4 Builds on a Fully Electrified Formula with New Woodland Capability and Expanded Charging Convenience9:00:00 AM ET

NXTS · NASDAQ

Nexentis Technologies Inc.

$0.55 -0.01 (-1.77%)

Company overview

Nexentis Technologies Inc., through its subsidiary, develops therapeutics related to cancer and inflammatory metabolic diseases. It operates through two segments, Biotechnology Activity and Renewable Energy Projects. The company's pipeline includes MITOLINE, an algorithm used to perform multiple sequence/ structure pairwise alignments which could then be used for generating a 3D comparative model of potentially all mitochondrial carrier proteins; cloud-based computational chemistry platform; and novel in-vitro screening platforms; and advanced 3D NSCLC tumor spheroid systems.The company was formerly known as N2OFF, Inc. and changed its name to Nexentis Technologies Inc. in February 2026. Nexentis Technologies Inc. was incorporated in 2009 and is headquartered in Ness Ziona, Israel.

Sector
Basic Materials
Industry
Agricultural Inputs
Exchange
NASDAQ
Market cap
$31,127
Employees
9
Headquarters
Ness Ziona, TA
Website
nexentistech.com
CEO
David Palach
Listed
February 26, 2026
P/E
0.00
Dividend yield
0.00%

Price chart

-0.435.8612.1518.4424.73
NXTS 1D NASDAQ O0.58H0.58L0.53C0.56-0.01 (-1.60%)Vol64.32K

News

15-min delaySigned-out view is delayed 15 minutes. Log in on Pro for the live news desk.

Start 7-day free trial See live plans
Source
Date
Type
View
Ticker Type Headline Source Published
NXTSNexentis Technologies Inc. Press release Nexentis Announces Reverse Stock Split GlobeNewswire
NXTSNexentis Technologies Inc. Press release Nexentis: MitoCareX Completes Initial AI-Powered Computational Screening Milestone with Boltz GlobeNewswire
NXTSNexentis Technologies Inc. Press release Nexentis: MitoCareX Bio Advances AI-Driven Drug Discovery Initiative with Boltz, Completing Initial Computational Screening Stage GlobeNewswire
NXTSNexentis Technologies Inc. Press release Nexentis: MitoCareX Bio Expands Computational Biology Capabilities to Advance Disease-Pathway Analysis GlobeNewswire
NXTSNexentis Technologies Inc. Stock news Nexentis: MitoCareX Bio Deploys its Computational Drug Discovery Infrastructure on Google Cloud GlobeNewswire
NXTSNexentis Technologies Inc. Press release Nexentis: MitoCareX Strengthens Its Computational Drug Discovery Capabilities with Appointment of Prof. Dan T. Major to Scientific Advisory Board GlobeNewswire
NXTSNexentis Technologies Inc. Press release Nexentis: MitoCareX Evaluates Expanded Protein Capabilities to Enhance Flexibility and Support Future Drug Discovery GlobeNewswire
See more
FAQ

Questions about Nexentis Technologies Inc.

What does Nexentis Technologies Inc. do?
Nexentis Technologies Inc., through its subsidiary, develops therapeutics related to cancer and inflammatory metabolic diseases. It operates through two segments, Biotechnology Activity and Renewable Energy Projects. The company's pipeline includes MITOLINE, an algorithm used to perform multiple sequence/ structure pairwise alignments which could then be used for generating a 3D comparative model of potentially all mitochondrial carrier proteins; cloud-based computational chemistry platform; and novel in-vitro screening platforms; and advanced 3D NSCLC tumor spheroid systems.The company was formerly known as N2OFF, Inc. and changed its name to Nexentis Technologies Inc. in February 2026. Nexentis Technologies Inc. was incorporated in 2009 and is headquartered in Ness Ziona, Israel.
What is NXTS's market cap?
Nexentis Technologies Inc. (NXTS) is a listed stock with a live quote. The latest market cap on this page is $31,127.
Where is Nexentis Technologies Inc. headquartered?
Nexentis Technologies Inc. is headquartered in Ness Ziona, TA.
How do I get NXTS news from the API?
Call GET /v1/news?tickers=NXTS. Add type=news, type=press_release, or type=legal to take one feed. Pro keys search articles since 2020 in real time. Free keys are delayed 15 minutes and return the last year. Signed-out visitors and Free accounts see that same year on this page. Pro sees articles since 2020.
How far back does NXTS news go?
Signed-out visitors and Free accounts see the last year of stock news, press releases, and legal notices for NXTS, 15 minutes behind, and each headline links to the publisher. Pro, including the 7-day trial, sees articles since 2020 as headlines are ingested. A Free API key returns the last year. Pro keys search articles since 2020.
Is the NXTS price on this page from the API?
The price and daily change update during the US session for every visitor. That quote is context on this page. It is not part of the news API. The chart is one candle per session from the start of 2020. 1W, 1M, and 1Y group those sessions.
Can I use the Pro plan commercially?
No. The Pro plan cannot be used for commercial work. A product you sell, work you do for a client, or redistribution of the feed needs a custom plan and a license. Email [email protected].

Real-time stock news for $15 a month.

Start a 7-day Pro trial. A card is required. REST, WebSocket, and MCP are included, with 250 REST requests a day, 1 WebSocket connection, 5 requests per second, and 2,500 WebSocket messages a day. You won't be charged during the trial. Unless you cancel, the card is billed for Pro when it ends.

Start 7-day free trial Read the docs